Masimo Corporation (NASDAQ:MASI) Short Interest Update

Masimo Corporation (NASDAQ:MASI) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 2,680,885 shares, a decline of 30.0% from the February 26th total of 3,828,135 shares. Based on an average trading volume of 1,848,469 shares, the short-interest ratio is presently 1.5 days. Currently, 6.0% of the company’s shares are short sold.

Hedge Funds Weigh In On Masimo

Several institutional investors have recently made changes to their positions in the company. Naya Capital Management UK Ltd. purchased a new position in Masimo during the 4th quarter valued at about $202,984,000. AQR Capital Management LLC raised its holdings in shares of Masimo by 3,416.5% in the 4th quarter. AQR Capital Management LLC now owns 1,091,326 shares of the medical equipment provider’s stock valued at $141,938,000 after purchasing an additional 1,060,292 shares in the last quarter. Viking Global Investors LP purchased a new stake in shares of Masimo in the 2nd quarter worth approximately $129,096,000. Squarepoint Ops LLC boosted its stake in shares of Masimo by 738.8% during the third quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock valued at $91,619,000 after purchasing an additional 546,905 shares in the last quarter. Finally, UBS Group AG boosted its stake in shares of Masimo by 252.9% during the fourth quarter. UBS Group AG now owns 599,274 shares of the medical equipment provider’s stock valued at $77,942,000 after purchasing an additional 429,474 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Trading Up 0.1%

Shares of NASDAQ MASI traded up $0.22 during trading hours on Friday, reaching $177.11. The stock had a trading volume of 1,134,695 shares, compared to its average volume of 1,976,752. Masimo has a 52-week low of $125.94 and a 52-week high of $179.00. The firm has a market cap of $9.51 billion, a price-to-earnings ratio of -16.80, a P/E/G ratio of 1.79 and a beta of 1.21. The business’s fifty day moving average price is $159.93 and its two-hundred day moving average price is $148.32. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on MASI shares. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Monday, December 1st. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Stifel Nicolaus set a $180.00 target price on Masimo in a research report on Tuesday, February 17th. Finally, Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday. Eight investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $181.17.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.